Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.68 - $3.63 $1,340 - $1,815
-500 Reduced 6.1%
7,700 $26,000
Q4 2023

Jan 30, 2024

BUY
$2.97 - $8.6 $24,354 - $70,520
8,200 New
8,200 $27,000
Q2 2022

Jul 25, 2022

SELL
$2.23 - $7.81 $3,568 - $12,496
-1,600 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$7.03 - $17.29 $11,248 - $27,664
1,600 New
1,600 $11,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $54.6M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.